@InvestorSince21 Avatar @InvestorSince21 TheIntelligentInvestor

TheIntelligentInvestor posts on X about $oscr, health, novo, $nvo the most. They currently have [---] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [---] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 78.3% finance 26.42% automotive brands 10.38% technology brands 3.77% cryptocurrencies 1.89% currencies 0.94% countries 0.94% social networks 0.94%

Social topic influence $oscr #114, health 57.55%, novo 11.32%, $nvo 10.38%, ai 7.55%, bullish 7.55%, target 6.6%, future 6.6%, ceo 5.66%, insurance 5.66%

Top accounts mentioned or mentioned by @conqcook @notbot12321 @mtbert @stockchaser @alex70848763197 @oscarhealth @mariots @edyy55 @investingwithac @xpengmotors @mrmajestic101 @thetrader7105 @atsohom @grok @joemilneredh @theronnievshow @serranoreymiami @sharkchart @prohumanistx @crankijames

Top assets mentioned Oscar Health, Inc. (OSCR) Novo-Nordisk (NVO) XPENG INC. (XPEV) UnitedHealth Group (UNH) ZetaChain (ZETA) Tesla, Inc. (TSLA) Alphabet Inc Class A (GOOGL) Eli Lilly and Company (LLY)

Top Social Posts

Top posts by engagements in the last [--] hours

"Since there were a few requests for a long-term Oscar Health $OSCR chart here it is: Oscar is currently in wave (3) of its wave III. The standard wave III target is the [-----] Fibonacci extension at $46 easily reachable within one year. This would be followed by wave IV and then wave V with a target at the [-----] Fibonacci extension of $68. That could occur in around three years and represents a 4x return from current levels. These are base targets; if unexpected extremely positive news emerges for Oscar they can expand adding roughly $20 to each target. The timelines I mentioned are not"
X Link 2026-01-12T20:23Z [---] followers, [----] engagements

"Under CEO Mark Bertolini's @mtbert visionary leadership Oscar Health $OSCR leverages AI and data analytics to personalize care driving member retention above 80%. Strategic partnerships and a robust pipeline position it as the frontrunner in consumer-centric health solutions"
X Link 2026-01-15T18:55Z [---] followers, [---] engagements

"@TheRonnieVShow Its beautiful to see different TAs align to the same price targets. My Elliott Wave Chart for Oscar Health $OSCR also indicates a target of around $45"
X Link 2026-01-20T07:42Z [---] followers, [---] engagements

"In a healthcare landscape craving disruption Oscar Health $OSCR delivers with its tech-driven model: Q3 [----] revenue up 23% YoY to $3B membership surging to 2.1M. With a P/S ratio under 0.4x and profitability targeted for [----] this undervalued stock offers asymmetric upside for discerning investors https://twitter.com/i/web/status/2014042204172431869 https://twitter.com/i/web/status/2014042204172431869"
X Link 2026-01-21T18:27Z [---] followers, [----] engagements

"It's great to see the CTO and cofounder of my favorite company $OSCR liking my tweets. Thank you for your hard work at Oscar Health @mariots"
X Link 2026-01-21T19:38Z [---] followers, [----] engagements

"Nice picks with $JD and Oscar Health $OSCR On XPeng $XPEV concerns are valid amid EV volatility but it's a tech leader in AI autonomy with the P7+ sedan's Turing chip enabling Level [--] features via [----] OTA updates. Deliveries jumped 126% to [------] in [----] eyeing [------] in [----] via global expansion to [--] countries. Revenue grew 33% to 40.87B CNY in [----] losses narrowed 44% with $6.79B cash and Volkswagen ties fueling R&D. At $20/share 1.5x EV/Sales seems undervalued for 33%+ revenue CAGR. https://twitter.com/i/web/status/2014214158732992663 https://twitter.com/i/web/status/2014214158732992663"
X Link 2026-01-22T05:50Z [---] followers, [---] engagements

"Bullish on Oscar Health $OSCR's moat: full-stack tech platform driving superior care at lower costs. [----] guidance reaffirms $12B+ revenue with [----] profitability in sight. Trading well below peers despite explosive growth"
X Link 2026-01-26T18:22Z [---] followers, [---] engagements

"I am buying every dip in Oscar Health $OSCR"
X Link 2026-01-27T19:37Z [---] followers, [----] engagements

"Oscar Health $OSCR is the best company out there Change my mind"
X Link 2026-01-27T19:57Z [---] followers, [----] engagements

"Oscar Health $OSCR: From net losses to Q1 [----] profitability ($275M) Oscar's trajectory is clear. Membership +41% YoY to over 2M with disciplined pricing fueling margin expansion. At current valuations this is a high-conviction hold for those betting on tech's role in healthcare reform https://twitter.com/i/web/status/2016550683336462815 https://twitter.com/i/web/status/2016550683336462815"
X Link 2026-01-28T16:35Z [---] followers, [----] engagements

"Amid ongoing industry challenges Oscar Health $OSCR delivered 56% revenue growth to $9.2B in [----] achieving its first-ever annual net profit of $25M. It remains on track for [----] with reaffirmed guidance of $1212.2B in revenue (3133% growth) and an Adjusted EBITDA loss of $80180M due to a higher MLR (8687%). Its AI-driven platform boosts engagement and efficiency making Oscar my favorite stock for [----] https://twitter.com/i/web/status/2016872858186645993 https://twitter.com/i/web/status/2016872858186645993"
X Link 2026-01-29T13:55Z [---] followers, [----] engagements

"In a healthcare landscape craving disruption Oscar Health $OSCR's tech-driven model is delivering: Q3 [----] revenue up 23% YoY and membership surging to [---] million. With a P/S ratio just above 0.3x and profitability on the horizon for [----] this undervalued stock offers asymmetric upside https://twitter.com/i/web/status/2016929906454634805 https://twitter.com/i/web/status/2016929906454634805"
X Link 2026-01-29T17:42Z [---] followers, [----] engagements

"I just love Oscar Health $OSCR"
X Link 2026-01-29T21:53Z [---] followers, [---] engagements

"I value your contrarian take on UnitedHealth Group $UNH Let's balance it with a nuanced bearish view: risks include 1.3M1.4M Medicare Advantage member losses from pruning unprofitable plans DOJ scrutiny of Optum deals and policy uncertainties such as Medicare spending cuts that could squeeze reimbursements. Rising medical costs with the full-year [----] medical loss ratio at 89.1% add pressure on margins. Yet UNH's shift to profitability-first growth appears resilient. [----] delivered 12% revenue growth to $447.6B adjusted EPS of $16.35 (beating estimates) and $19.7B in cash flow (1.5x net"
X Link 2026-01-30T18:35Z [---] followers, [---] engagements

"Oscar Health $OSCR: Final CMS data shows ACA enrollment down just -4.94% YoYway better than the feared 15-20% cliff With pricing up 28% and potential subsidy extensions ahead this setup is primed for liftoff. Get ready 🚀"
X Link 2026-01-30T20:17Z [---] followers, [----] engagements

"@StockChaser_ Oscar Health $OSCR"
X Link 2026-02-02T07:34Z [---] followers, [---] engagements

"@StockChaser_ Oscar Health $OSCR without a doubt"
X Link 2026-02-02T12:57Z [---] followers, [----] engagements

"Novo Nordisk $NVO's strategic prowess in tackling global health crises is unmatched. As the pioneer of the first oral GLP-1 for weight loss Wegovy pill's broad U.S. availability in [----] and fuels momentum amid rising obesity demands. Coupled with a robust pipeline including potential CagriSema approval and Amycretin advancements the long-term upside is compelling https://twitter.com/i/web/status/2018357549070799054 https://twitter.com/i/web/status/2018357549070799054"
X Link 2026-02-02T16:15Z [---] followers, [---] engagements

"Oscar Health $OSCR continues to disrupt traditional insurance with its AI-powered platform driving impressive revenue growth to expected $12B+ in [----]. As telehealth surges their tech-first approach positions them for sustained profitability and market leadership"
X Link 2026-02-02T16:55Z [---] followers, [----] engagements

"Oscar Health $OSCR keeps going down and is now red YTD. Nevertheless the chart looks very bullish for Oscar As soon as wave (ii) is finished it should begin wave (iii) with a minimum target of $23.62. The catalyst for the start of wave (iii) may be an ACA extension or great earnings. The latter has the potential to extend wave (iii) which would then mean a target of $29.59 if the earnings are extraordinary I maintain my investment in @OscarHealth and add to my position on every dip. https://twitter.com/i/web/status/2018401653469089827 https://twitter.com/i/web/status/2018401653469089827"
X Link 2026-02-02T19:10Z [---] followers, [----] engagements

"@Edyy55 The management of Oscar Health $OSCR made clear that they didn't factor in an ACA extension in der guidance. Additionally if the ACA doesn't get extended this may be a good chance to expand their ICHRA market"
X Link 2026-02-02T22:00Z [---] followers, [---] engagements

"@SerranoReyMiami @investingwithac The management of Oscar Health $OSCR made clear that they didn't factor in an ACA extension in der guidance. Additionally if the ACA doesn't get extended this may be a good chance to expand their ICHRA market"
X Link 2026-02-03T06:18Z [---] followers, [---] engagements

"A nice brief overview of NovoNordisk $NVO: $NVO is still severely undervalued Even after the 35% push Novo is still trading at: 16.2x PE 25x P/FCF 13x P/OCF While delivering: 23% 4Y revenue CAGR 24% 4Y net income CAGR Thats real growth at massive scale With the Wegovy pill lifting top-line https://t.co/RO02foiX0p $NVO is still severely undervalued Even after the 35% push Novo is still trading at: 16.2x PE 25x P/FCF 13x P/OCF While delivering: 23% 4Y revenue CAGR 24% 4Y net income CAGR Thats real growth at massive scale With the Wegovy pill lifting top-line https://t.co/RO02foiX0p"
X Link 2026-02-03T07:00Z [---] followers, [----] engagements

"If this scenario were to unfold it would undoubtedly represent a meaningful near-term setback for Oscar Health $OSCR both operationally and in terms of market perception. A misstep of that magnitude from the CEO would understandably disappoint investors and stakeholders potentially eroding confidence in leadership and the company's short term execution. That said even in such a challenging case I remain convinced that Oscar Health's core vision and technological foundation position it to drive meaningful lasting change in the healthcare industry. The company's focus on consumer-centric"
X Link 2026-02-03T09:24Z [---] followers, [---] engagements

"Just one week until Oscar Health $OSCR reports its earnings"
X Link 2026-02-03T16:29Z [---] followers, [---] engagements

"Bullish on Novo Nordisk $NVO: Leadership in diabetes and obesity care drives sustained volume growth supported by structural tailwinds from rising global prevalence. Recent UK approval Amazon partnership and rapid oral Wegovy uptakedespite rival delaysposition it for earnings beats and upward revisions in [----]. #NovoNordisk #Investing #GLP1 https://twitter.com/i/web/status/2018724291563360380 https://twitter.com/i/web/status/2018724291563360380"
X Link 2026-02-03T16:32Z [---] followers, [---] engagements

"As legacy insurers grapple with outdated systems Oscar Health $OSCR leverages cutting-edge AI to redefine efficiency. Membership has soared past [--] million with aggressive 28% premium hikes for [----] and a clear path to margin expansion. This is the future of personalized affordable care https://twitter.com/i/web/status/2018786545344365056 https://twitter.com/i/web/status/2018786545344365056"
X Link 2026-02-03T20:39Z [---] followers, [---] engagements

"I'm considering starting a position in $ZETA. A lot of smart people I follow on X are invested in it and what I saw in my first short deep dive I liked a lot. I plan to dive deeper in the coming days/weeks. What do you guys think of Zeta"
X Link 2026-02-03T21:31Z [---] followers, [---] engagements

"Oscar Health $OSCR isn't just insurance It's a scalable tech platform transforming the $5T US healthcare market. With Q4 earnings on the horizon expect highlights on double-digit growth and AI efficiencies"
X Link 2026-02-03T21:42Z [---] followers, [----] engagements

"@investingwithac Oscar Health $OSCR without a doubt"
X Link 2026-02-04T06:03Z [---] followers, [---] engagements

"Oscar Health $OSCR: From cash-burn narrative to profitability powerhouse. AI agents streamline claims ACA market share expands and Q3 revenue surges 23% YoYall while trading below peers. As telehealth booms this is the AIplay in health insurance. Eyes on February [--] earnings"
X Link 2026-02-04T17:38Z [---] followers, [----] engagements

"Bullish on $XPEV as the IRON humanoid strides into the spotlight [---] cm of agile intelligent engineering. From its Shenzhen debut to [----] mass deployment @XPengMotors is accelerating the humanoid revolution. The future is electric and robotic âš¡"
X Link 2026-02-04T18:00Z [---] followers, [---] engagements

"A little reminder of the bigger picture for Oscar Health $OSCR: The chart admittedly isnt what youd call beautiful. However the fundamentals and future potential I see are so strong that I dont mind the current price action. As long as @OscarHealth holds around the blue [-----] Fibonacci and doesnt drop below the wave (2) low the chart remains active. If it does break below a new wave (2) and potentially a new wave II low comes into play. In an extreme scenario this could take it down to the red [-----] Fibonacci near $10 which would be a brilliant entry point. In that case I would double my"
X Link 2026-02-04T18:22Z [---] followers, [----] engagements

"Normally I agree with you. I also look for undervalued companies and then plan entries with technical analysis. But with Oscar Health $OSCR I want to load up on as many shares as possible because I truly believe in the company. Also the chart does align with the bullish thesis it is just not as clear as in other stocks like Novo Nordisk $NVO for example. https://twitter.com/i/web/status/2019137973346865344 https://twitter.com/i/web/status/2019137973346865344"
X Link 2026-02-04T19:56Z [---] followers, [---] engagements

"I support XPeng for blending AI with electric cars to transform mobility. Their homegrown tech like Xmart OS and XPILOT drives green innovation and makes advanced user-friendly rides accessible in the smart mobility wave. $XPEV is the $TSLA of China. It also works on humanoid robots flying cars and more https://twitter.com/i/web/status/2019291038792233149 https://twitter.com/i/web/status/2019291038792233149"
X Link 2026-02-05T06:04Z [---] followers, [---] engagements

"$OSCR $OSCR - Google search trends for Oscar Health over the last [--] years 🚀 February 10th we shock the world. https://t.co/XDypiauPEH $OSCR - Google search trends for Oscar Health over the last [--] years 🚀 February 10th we shock the world. https://t.co/XDypiauPEH"
X Link 2026-02-05T16:38Z [---] followers, [---] engagements

"Didn't think I would manage to get Oscar Health $OSCR again in the $12s. What a great opportunity"
X Link 2026-02-05T18:01Z [---] followers, [----] engagements

"As legacy insurers grapple with margin compression Oscar Health $OSCR thrives on innovation: complimentary telehealth AI optimizations and a 30% forward topline growth trajectory. At under $4B market cap against $12B projected revenue Oscar Health represents asymmetric upside in the telehealth AI wave. https://twitter.com/i/web/status/2019512578922209477 https://twitter.com/i/web/status/2019512578922209477"
X Link 2026-02-05T20:44Z [---] followers, [----] engagements

"That Oscar Health $OSCR has a market cap below $3.5B is just crazy"
X Link 2026-02-05T21:28Z [---] followers, [----] engagements

"Can we get the red [-----] Fibonacci at $10.22 @OscarHealth Would be a generational buying opportunity The chance to get Oscar Health $OSCR below $12 is crazy A little reminder of the bigger picture for Oscar Health $OSCR: The chart admittedly isnt what youd call beautiful. However the fundamentals and future potential I see are so strong that I dont mind the current price action. As long as @OscarHealth holds around the blue https://t.co/kaagzSIUIR A little reminder of the bigger picture for Oscar Health $OSCR: The chart admittedly isnt what youd call beautiful. However the fundamentals and"
X Link 2026-02-05T21:39Z [---] followers, [----] engagements

"Help me I can't stop buying Oscar Health $OSCR"
X Link 2026-02-05T22:52Z [---] followers, [----] engagements

"How can it be real that I managed to get Oscar Health $OSCR shares at $11.65 in 2026"
X Link 2026-02-05T22:58Z [---] followers, [----] engagements

"Oscar Health $OSCR reports earnings tomorrow Let's see what they bring"
X Link 2026-02-09T12:04Z [---] followers, [----] engagements

"Do you want an Oscar Health $OSCR chart today Yes No Yes No"
X Link 2026-02-09T12:26Z [---] followers, [----] engagements

"Oscar Health $OSCR beat on EPS and MLR in Q3 signaling operational mastery. CEO Bertolini (@mtbert) confidently projects a [----] profitability rebound. Membership has surged 13000% since inception and ICHRA expansion positions Oscar as the future of individualized healthcare marketplaces. Looking forward to its earnings tomorrow https://twitter.com/i/web/status/2020863265694171609 https://twitter.com/i/web/status/2020863265694171609"
X Link 2026-02-09T14:12Z [---] followers, [----] engagements

"Did you know that Oscar Health $OSCR's pioneering AI-driven platform including tools like Oswell personalizes member care plans by leveraging predictive analytics to anticipate health needs and reduce unnecessary expenditures This tech innovation supports the company's reaffirmed guidance for approximately 3133% year-over-year revenue growth in [----] projecting over $12.0 billion in total revenue. As we enter [----] with disciplined pricing (including an average 28% rate increase for ACA plans) expansion into new states such as Alabama and Mississippi and ongoing AI efficiencies this health tech"
X Link 2026-02-09T15:14Z [---] followers, [----] engagements

"Oscar Health $OSCR is charting a course to profitability in [----] leveraging its tech-driven model for disciplined growth and premium expansions. With recent EBITDA milestones and a focus on medical cost management it's poised to disrupt traditional insurers. Earnings tomorrow could ignite momentum https://twitter.com/i/web/status/2020903013138018323 https://twitter.com/i/web/status/2020903013138018323"
X Link 2026-02-09T16:49Z [---] followers, [----] engagements

"In an era of precision therapeutics Novo Nordisk $NVO's data-driven approach yields unmatched efficacy in metabolic disorders. Recent acquisitions bolster their AI-integrated drug discovery forecasting a 25% pipeline success rate premium"
X Link 2026-02-09T17:16Z [---] followers, [---] engagements

"I am planning on uploading updates on Oscar Health $OSCR and Novo Nordisk $NVO. Drop any other stocks you want charted in the comments"
X Link 2026-02-09T17:20Z [---] followers, [----] engagements

"The chart for Oscar Health $OSCR depends on tomorrow's earnings: Bullish earnings (expected): $OSCR should begin wave (3) and reclaim all important moving averages. Wave (3) target is $30.60. Mid earnings (unlikely): Oscar would then consolidate between the red 0.50.618 Fibonacci until the market discovers its real value. Bad earnings (very unlikely): Oscar would then drop to at least the [-----] Fibonacci at $10.22 possibly even to the [-----] (not on the chart) at $6.63. I personally expect bullish earnings since most potential negative factors are already priced into the share price."
X Link 2026-02-09T19:12Z [---] followers, [----] engagements

"Novo Nordisk $NVO behaved as forecasted in the last few chart updates. It dropped from its wave (5)/I high at $62.39 to its wave II low at $43.25. It is now in subwave (1) of wave III. The wave III target is $74.48. I see no obstacles preventing Novo from reaching this target. The threat from $HIMS's GLP-1 is also out of the way. I remain invested in Novo and consider to add to my position on a subwave (2) pullback A lot of people doubted my chart of Novo Nordisk $NVO Nevertheless the stock moved exactly as expected and pulled back to its [-----] Fibonacci level. Once support holds wave III is"
X Link 2026-02-09T19:35Z [---] followers, [---] engagements

"$NIO's momentum is electric: surpassing [---] million battery swaps planning [----] new stations and delivering Q4 [----] profits amid 71% delivery growth. This isnt just expansionits a scalable blueprint for global EV adoption"
X Link 2026-02-09T21:13Z [---] followers, [---] engagements

"Oscar Health $OSCR showcases resilient growth in Q4 & FY 2025: Revenue climbs 27% YoY to $11.7B fueled by innovative offerings. With enhanced efficiency & [----] guidance of $18.7-19B revenue & $250-450M operating earnings Oscar is primed for huge upside"
X Link 2026-02-10T13:09Z [---] followers, [---] engagements

"Last quarter may have been a miss but the guidance is extraordinary. At the latest after the next earnings when Oscar Health $OSCR beats the market should acknowledge its real worth and bring it to $40+"
X Link 2026-02-10T13:32Z [---] followers, [----] engagements

"I must be honest Although Im really convinced about Oscar Health $OSCR and absolutely trust its CEO @mtbert did I feel a little queasy before its earnings since Oscar is currently around 22% of my portfolio"
X Link 2026-02-10T13:51Z [---] followers, [----] engagements

"Which chart do you want today $NIO or $UNH Every stock you drop in the comments I will chart too. Nio United Health Nio United Health"
X Link 2026-02-10T14:16Z [---] followers, [---] engagements

"@ConqCook Patience is the key to investing. You need to find undervalued companies and then you need patience. Great things take time"
X Link 2026-02-10T15:55Z [---] followers, [--] engagements

"@ConqCook This short-term pain I can understand. But take it as a lesson and choose analytical thinking instead of emotional thinking"
X Link 2026-02-10T16:09Z [---] followers, [--] engagements

"@ConqCook I don't know what you mean by "the increase in the value of the shares" since Oscar Health $OSCR did drop 66% since its IPO"
X Link 2026-02-10T18:23Z [---] followers, [--] engagements

"Oscar Health $OSCR is quietly building a monster in the ACA. It exited [----] with 2.04M members and $11.7B in revenue then guided to $18.7B$19.0B revenue and $250M$450M earnings from operations in [----]. Scale and profitability in the same sentence hits different"
X Link 2026-02-10T18:54Z [---] followers, [----] engagements

"@mrmajestic101 I wouldnt call this nothing"
X Link 2026-02-11T10:44Z [---] followers, [--] engagements

"Transforming lives through science Novo Nordisk $NVO's commitment to sustainable healthcare innovation from insulin pioneer to obesity disruptor fuels a compelling growth narrative I see huge upside for Novo in the long run"
X Link 2026-02-11T16:14Z [---] followers, [---] engagements

"Oscar Health $OSCR redefines health insurance with tech innovation at its core. Q4'25 results show record 3.4M members and $11.7B FY revenuea 27% YoY surge. With [----] guidance projecting $18.7-19B revenue and profitability OSCR's scalable model positions it as a leader in personalized care. Thank you @mtbert @mariots and the rest of the team https://twitter.com/i/web/status/2021624265989054902 https://twitter.com/i/web/status/2021624265989054902"
X Link 2026-02-11T16:35Z [---] followers, [---] engagements

"Do you want an article or thread on Oscar Health $OSCR"
X Link 2026-02-11T18:04Z [---] followers, [----] engagements

"Oscar Health's $OSCR Q4 [----] earnings underscore resilience: $2.8B revenue (up 17% YoY) capping a year of $11.7B total amid membership growth to 3.4M. Forward guidance for 2026over 60% revenue growth to $19B and profitabilityhighlights operational leverage and market penetration. As healthcare digitizes OSCR's platform stands out for value creation https://twitter.com/i/web/status/2021685173159330051 https://twitter.com/i/web/status/2021685173159330051"
X Link 2026-02-11T20:38Z [---] followers, [---] engagements

"What is your favorite stock Mine is Oscar Health $OSCR Drop yours in the comments"
X Link 2026-02-11T20:40Z [---] followers, [----] engagements

"@TheTrader7105 I know that many of my followers are interested in $ZETA. Therefore I am currently doing a deep dive into it"
X Link 2026-02-11T21:03Z [---] followers, [---] engagements

"Leading the charge in metabolic innovation Novo Nordisk $NVO's GLP-1 portfolio drives obesity and diabetes management fueled by strong semaglutide demand. Q4 [----] sales surged 30% YoY at CER with full-year growth of 26%. Pipeline expansions include CV risk-reduction approvals for semaglutide including the oral formextending benefits to heart health beyond glucose control and weight loss. https://twitter.com/i/web/status/2022020973264875574 https://twitter.com/i/web/status/2022020973264875574"
X Link 2026-02-12T18:52Z [---] followers, [---] engagements

"@atsohom For real Novo Nordisk $NVO is in deeply undervalued territory right now"
X Link 2026-02-13T11:31Z [---] followers, [---] engagements

"95 likes that's crazy It seems you guys really want a thread and an article on Oscar Health $OSCR. I'm working on them now and expect to finish over the weekend. Expected completion: Monday. Have a nice weekend Do you want an article or thread on Oscar Health $OSCR Do you want an article or thread on Oscar Health $OSCR"
X Link 2026-02-13T11:49Z [---] followers, [----] engagements

"@Notbot12321 Why do you think so"
X Link 2026-02-13T21:54Z [---] followers, [--] engagements

"What are your three largest positions Mine are: Oscar Health $OSCR XPeng $XPEV UnitedHealth $UNH Drop yours in the comments"
X Link 2026-02-04T18:29Z [---] followers, [----] engagements

"I play with the thought of buying one This car looks really great @XPengMotors. Well done $XPEV Round [--] More stunning shots of the all-new XPENG GX our first flagship 6-seater SUV. Driven by love. Engineered for the future. AI-powered luxury true 6-seater comfort and the ultimate family flagship. Where will you take it first $XPEV https://t.co/Ahb4bFOOaE Round [--] More stunning shots of the all-new XPENG GX our first flagship 6-seater SUV. Driven by love. Engineered for the future. AI-powered luxury true 6-seater comfort and the ultimate family flagship. Where will you take it first $XPEV"
X Link 2026-02-06T18:55Z [---] followers, [---] engagements

"$NIO isnt trading like a company that has crossed [-------] EVs on the road posted record deliveries and is pushing toward its first profitable yearits trading like the market forgot how inflection points are priced"
X Link 2026-02-13T17:12Z [---] followers, [----] engagements

"@Notbot12321 @grok Do you have any reliable sources on this or is this pure speculation"
X Link 2026-02-13T22:04Z [---] followers, [--] engagements

"@Alex70848763197 Okay it's a deal How long did it take you Do you think I get it done over the weekend"
X Link 2026-02-13T22:18Z [---] followers, [--] engagements

"@SharkChart $OSCR"
X Link 2026-02-14T10:55Z [---] followers, [---] engagements

"Oscar Health $OSCR's pivot to profitability underscores its tech-first advantage outpacing peers in enrollment. As CEO Bertolini aptly puts it: a "pirate ship" ready to claim market share. [----] guidance is incredible"
X Link 2026-02-10T14:32Z [---] followers, [---] engagements

"Bullish on Oscar Health $OSCR: Achieved $11.7B FY revenue with robust 27% growth and membership soaring to 3.4M. Despite [----] headwinds [----] guidance of $18.719B revenue and positive earnings confirms strong execution. OSCRs tech-enabled ecosystem is transforming insurance accessibility and efficiency https://twitter.com/i/web/status/2021958610385858988 https://twitter.com/i/web/status/2021958610385858988"
X Link 2026-02-12T14:44Z [---] followers, [---] engagements

"If this tweet gets - [--] likes then I will create a thread - [--] likes then I will create an article and a thread on Oscar Health $OSCR Do you want an article or thread on Oscar Health $OSCR Do you want an article or thread on Oscar Health $OSCR"
X Link 2026-02-12T17:36Z [---] followers, [---] engagements

"In a sector ripe for disruption Oscar Health $OSCR delivers: FY'25 revenue hits $11.7B on 27% growth fueled by 2.0M members. Despite near-term pressures the [----] outlook$18.7-19B revenue and positive earningssignals a pivotal profitability inflection. I see OSCR's data-driven approach as a blueprint for efficient member-centric insurance https://twitter.com/i/web/status/2022335305563414734 https://twitter.com/i/web/status/2022335305563414734"
X Link 2026-02-13T15:41Z [---] followers, [---] engagements

"$NIO is currently either at the beginning of wave III or at the end of wave II. It dropped from its wave I high at $8.02 to between the [-----] and [-----] Fibonacci levels. As the chart shows the [-----] Fib is a very important level having been tested frequently from both above and below. Right now the price is slightly above this level but it cannot yet be considered successfully converted to support. The price is also above the 50- and 200-hour MAs which in this case appear to have been converted to support. Bullish scenario: NIO manages to convert the [-----] Fibonacci level and builds an"
X Link 2026-02-10T17:48Z [---] followers, [----] engagements

"UnitedHealth $UNH is currently either at the start of wave III or at the end of wave II. It is now below all key moving averages and needs to turn them into support. Its next target is the wave III objective at the [-----] Fibonacci level of $496.11. The timeline for this target is not precise; it is placed close for visibility in the chart. The bearish scenario involves another lower low potentially dropping to the [-----] Fibonacci or even the larger red [-----]. I assign this scenario low probability. I do not plan to sell my position but I also do not want to add at current levels as I already"
X Link 2026-02-10T19:19Z [---] followers, [----] engagements

"@Alex70848763197 Thank you Hopefully it meets your expectations. My strength is in mathematics not in writing"
X Link 2026-02-16T09:20Z [---] followers, [--] engagements

"The main part of my position I started in summer but I also added significantly in November and February. I agree with your stance on $NVO that the difficult times are priced in and I see significant upside. On $LLY though I dont have an opinion since I havent looked deep enough into the company. https://twitter.com/i/web/status/2022430725123752278 https://twitter.com/i/web/status/2022430725123752278"
X Link 2026-02-13T22:00Z [---] followers, [--] engagements

"Everyones staring at Chinas #EV price war while $NIO quietly delivers 300k+ cars a year has achieved over 1M cumulative deliveries and targets full-year profitability. I think this risk/reward will age like one of those I shouldve known charts"
X Link 2026-02-14T12:51Z [---] followers, [----] engagements

"The market is still pricing $NIO like a speculative story not a company with over [-------] EVs delivered accelerating margins multi-brand scale and a clear path to operating profit"
X Link 2026-02-16T10:12Z [---] followers, [---] engagements

"@StockChaser_ Concentration in a few main stocks especially Oscar Health $OSCR but for the diversification additionally a bunch of other stocks with lighter weight"
X Link 2026-01-27T11:27Z [---] followers, [---] engagements

"Do you want a thread on the #gold and #silver rally If this post gets [--] likes I'll create one"
X Link 2026-01-27T12:17Z [---] followers, [---] engagements

"@StockChaser_ My objective is to build a conservative growth portfolio. I'm not aiming for explosive annual returns like 5x; rather I want to outperform the S&P [---] by double-digit percentage points"
X Link 2026-01-27T14:36Z [---] followers, [--] engagements

"Oscar Health's $OSCR membership has surged over 12000% since inception in [----] reaching over [--] million members and highlighting strong market traction. With Q2 [----] revenue at $2.9B (up 29%) and expansions into new states and ICHRA products $OSCR is poised for 20%+ revenue CAGR through [----]. https://twitter.com/i/web/status/2016204476193898605 https://twitter.com/i/web/status/2016204476193898605"
X Link 2026-01-27T17:39Z [---] followers, [----] engagements

"Despite ACA subsidies lapsing federally (with some state-level offsets) Oscar Health $OSCR adapts via 28% rate hikes for risk pool stabilization and potential enrollment growth. Recent technical consolidation in a cup-and-handle pattern hints at breakout potential. Fundamentals support upside to $45-55/share per CEO guidance. https://twitter.com/i/web/status/2016232423504412697 https://twitter.com/i/web/status/2016232423504412697"
X Link 2026-01-27T19:30Z [---] followers, [----] engagements

"I am really looking forward to Oscar Healths $OSCR earnings on the 10th of February"
X Link 2026-01-28T16:10Z [---] followers, [----] engagements

"The Fed's decision to maintain rates at 3.5%3.75% reflects a maturing economic landscape resisting external pressure to ease. It acknowledges inflation's decline while maintaining caution about future volatility"
X Link 2026-01-28T20:20Z [---] followers, [---] engagements

"In the ever-evolving landscape of healthcare innovation Novo Nordisk $NVO stands as a beacon of resilience and growth. With its stock up 22% year-to-date in [----] after a challenging [----] the launch of oral Wegovy is already rewriting the narrative with [-----] prescriptions in its second week outpacing competitors. With a P/E of [--] I consider it undervalued #NovoNordisk #NVO #HealthcareInvesting https://twitter.com/i/web/status/2016879378286756135 https://twitter.com/i/web/status/2016879378286756135"
X Link 2026-01-29T14:21Z [---] followers, [---] engagements

"In a high-interest-rate environment PayPal $PYPL's low-debt balance sheet stands out. Leveraging AI for personalized finance it's capturing market share from legacy banks. Target price: $100+. A bullish play on economic resilience"
X Link 2026-01-29T17:53Z [---] followers, [---] engagements

"UnitedHealth $UNH's [----] adjusted EPS guidance of $17.75 signals 9% growth from 2025s $16.35 with operating margins expanding to 5.5%. Despite revenue right-sizing this reflects disciplined focus on profitability and cash flow ($19.7B in 25) plus a forward P/E of 17"
X Link 2026-01-29T19:00Z [---] followers, [---] engagements

"The market obsesses over short-term noise while ignoring $NIO's fundamentals: record quarterly deliveries new model cadence battery swap network expansion and management's explicit profitability roadmap for [----]. Nio is an oversold premium EV leader with massive catch-up potential. Eyes on Q4 #NIO https://twitter.com/i/web/status/2016955757397250204 https://twitter.com/i/web/status/2016955757397250204"
X Link 2026-01-29T19:25Z [---] followers, [---] engagements

"@Prohumanistx Earnings are going to be interesting. I think it's time to share another Novo Nordisk $NVO chart update soon"
X Link 2026-01-29T21:42Z [---] followers, [---] engagements

"Novo Nordisk $NVO did move exactly like I expected It likely finished its wave (5)/I slightly below the [-----] Fibonacci then built an extended b-wave that made a higher high. The pullback needs to reach at least the [-----] Fibonacci but the most textbook move would be to the [---] or [-----]. The alternative scenario would be that wave (5) is just subwave [--] of (5) and the higher high b-wave would then be subwave i of subwave [--]. This would mean enormous short-term upside potential since 1-2-1-2 setups are very bullish. I think this scenario is very unlikely and has a low chance of happening. I hope"
X Link 2026-02-02T17:48Z [---] followers, [----] engagements

"@Edyy55 Why do market makers dump Oscars share price They want cheaper shares This means they believe in the stock"
X Link 2026-02-03T06:17Z [---] followers, [--] engagements

"@crankijames Joke's on you Novo Nordisk did exactly as expected in the chart You have much to learn about technical analysis"
X Link 2026-02-03T20:34Z [---] followers, [--] engagements

"A lot of people doubted my chart of Novo Nordisk $NVO Nevertheless the stock moved exactly as expected and pulled back to its [-----] Fibonacci level. Once support holds wave III is expected to push it above $80. The bearish scenario is an extended wave II taking it down to the [-----] Fib at $47. I personally do not intend to sell Novo but I want to add to my position as soon as support is confirmed. Novo Nordisk $NVO did move exactly like I expected It likely finished its wave (5)/I slightly below the [-----] Fibonacci then built an extended b-wave that made a higher high. The pullback needs to"
X Link 2026-02-03T20:47Z [---] followers, [----] engagements

"@Joe_Milner_EDH Sounds smart. How long are you intending to hold $AMZN and $META"
X Link 2026-02-04T20:34Z [---] followers, [---] engagements

"@Joe_Milner_EDH Sounds like a good plan"
X Link 2026-02-05T05:49Z [---] followers, [--] engagements

"@sen_investing I understand your feelings but you need to view investing from a higher timeframe. There will be a rotation from overvalued positions to severely undervalued ones like UnitedHealth"
X Link 2026-02-05T05:54Z [---] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing